cysteine has been researched along with Teratocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Häkli, M; Jänne, OA; Lorick, KL; Palvimo, JJ; Weissman, AM | 1 |
| DeAlmeida, VI; Ernst, JA; Koeppen, H; Miao, L; Polakis, P; Rubinfeld, B | 1 |
2 other study(ies) available for cysteine and Teratocarcinoma
| Article | Year |
|---|---|
Transcriptional coregulator SNURF (RNF4) possesses ubiquitin E3 ligase activity.
Topics: Amino Acid Motifs; Animals; Cell Line, Tumor; Chlorocebus aethiops; Chromatography, Gel; COS Cells; Cysteine; Glutathione; Ligases; Mice; Point Mutation; Precipitin Tests; Recombinant Fusion Proteins; Teratocarcinoma; Transcription, Genetic; Transfection; Ubiquitin; Ubiquitin-Protein Ligases | 2004 |
The soluble wnt receptor Frizzled8CRD-hFc inhibits the growth of teratocarcinomas in vivo.
Topics: Amino Acid Sequence; Animals; Cell Growth Processes; Cell Line, Tumor; Cysteine; Female; Humans; Immunoglobulin Fc Fragments; Mice; Mice, Nude; Molecular Sequence Data; Protein Structure, Tertiary; Receptors, G-Protein-Coupled; Recombinant Fusion Proteins; Teratocarcinoma; Transfection; Wnt1 Protein; Xenograft Model Antitumor Assays | 2007 |